rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Air Products and Chemicals, Inc.

APD · NYSE

MaterialsChemicalsJust started movingHydrogen Economy

APD stood above a rising 150-day average in 21 of the last 52 weekly readings, including each of the last 1 week. It is 2.0% above that average now. Chemicals: 25% of its 85 stocks in an uptrend (−1 points in four weeks); Materials: 18% (−6 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
1 in a row
Industry in uptrend
25% -1 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$41.5M
Officials’ trades on record
105

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 21 of 52 weeks.

20 Apr – 19 Oct
18%38%58%Apr 26Jun 26Jul 26Sep 26Oct 26

Chemicals: A minority of its stocks are in an uptrend and the share has held steady. Materials: Few of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$38.5M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

105 disclosed lines: House 88, Senate 8, executive 9; 32 people.

WhoDidAmountTraded
Richard McCormick House: U.S. House ClerkGA06sold$1k–$15k30 Jul 2026filed 14 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k15 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k15 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k10 Apr 2026filed 1 Jul 2026
Alan Armstrong Senate: U.S. Senate eFDSenatorbought$1k–$15k27 Mar 2026filed 21 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k17 Mar 2026filed 14 May 2026
Josh Gottheimer House: U.S. House ClerkNJ05boughtjoint$1k–$15k5 Mar 2026filed 8 Apr 2026
Julie Johnson House: U.S. House ClerkTX32soldjoint$1k–$15k18 Dec 2025filed 15 Jan 2026
Josh Gottheimer House: U.S. House ClerkNJ05soldjoint$15k–$50k8 Dec 2025filed 14 Jan 2026
Julie Johnson House: U.S. House ClerkTX32soldjoint$1k–$15k13 Nov 2025filed 11 Dec 2025
Richard McCormick House: U.S. House ClerkGA06bought$1k–$15k5 Nov 2025filed 9 Dec 2025
Lisa C. McClain House: U.S. House ClerkMI09soldspouse$1k–$15k25 Sep 2025filed 23 Oct 2025

Insiders

Buy orders, 12 months0
Sale orders, 12 months2
Buyers · sellers0 · 2
WhoDidSharesTraded
Melissa N. SchaefferExec Vice President and CFOsold2,714at $303.761 May 2026filed 4 May 2026
Mantle Ridge LpDirector, Othersold70,175at $284.2112 Feb 2026filed 13 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Alfred Stern Company insiderDirector · last 30 Sep 20260 · 0
Andrew W. Evans Company insiderDirector · last 30 Sep 20261 · 1
Bhavesh Patel V Company insiderDirector · last 30 Sep 20260 · 0
Dennis H. Reilley Company insiderDirector · last 30 Sep 20260 · 0
Howard I. Ungerleider Company insiderDirector · last 30 Sep 20260 · 0
Jessica Graziano Company insiderDirector · last 30 Sep 20260 · 0
Tonit M. Calaway Company insiderDirector · last 30 Sep 20260 · 0
Wayne Thomas Smith Company insiderDirector · last 30 Sep 20262 · 0
Matthew Lepore Company insiderEVP & General Counsel · last 18 Aug 20260 · 0
Richard McCormick HouseGA06 · last 30 Jul 20262 · 1
Donald J. Trump Executive branchWhite House Office · last 15 May 20263 · 1
Melissa N. Schaeffer Company insiderExec Vice President and CFO · last 1 May 20260 · 3

Same industry

FF FutureFuelLeading+19%
IOSP InnospecLeading+16%
MEOH MethanexLeading+11%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 30 Sep 202531.4%
Operating profit marginFY 2025 · to 30 Sep 2025-7.3%
Free cash flow marginFY 2025 · to 30 Sep 2025-31.3%
Return on capital employedFY 2025 · to 30 Sep 2025-2.4%
Cash conversionFY 2024 · to 30 Sep 202495.3%
Debt to equityFY 2025 · to 30 Sep 20250.00×
Research spendFY 2025 · to 30 Sep 20250.8%
Share count trendFY 2025 · to 31 Oct 20250.0%
Cash and equivalentsFY 2025 · to 30 Sep 2025$1.9B
Free cash flowFY 2025 · to 30 Sep 2025−$3.8B

Analyst forecasts

No analyst forecasts yet.